The peptide exhibits anabolic and metabolic activities through IGF-1 receptor binding, though it has never been approved for therapeutic human use and remains confined to research applications [12]
A group of researchers, including oncologists and data scientists, from the University of Florida and Indiana University hypothesized that GLP-1s hold promise in oncology due to their ability to lower glucose, adiposity, insulin resistance, and systemic inflammation factors associated with cancer progression, according to a July 2025 paper published in JAMA
Should I get my B12 levels tested before starting Retatrutide
Focus on simple, nourishing meals, stay hydrated, and listen to your body's signals
For weekly GLP-1 medications, patients might use the right abdomen one week, left abdomen the next, then alternate thighs, creating a four-week rotation cycle
The global TRIUMPH Phase 3 program is now assessing retatrutide in obesity , type 2 diabetes , obstructive sleep apnea , knee osteoarthritis , and cardiovascular outcomes